JPMorgan Healthcare Leaders ETF (JDOC)

Where do you get that optimism from? I wish I were like that, too. I’m in a tough spot right now—nothing health-related, just a breakup after 18 years. I’m also hoping for a share price in the mid-double-digit range.

I doubt Horntail was implying that he was honest. More like a response is better than no response. Still, I've pretty much written off this stock. On to the next..

Still no usual sell by Doug. And still no insider buying.

I guess the only good thing about alzheimers is that ya live longer but ya dont know where ya are

I HOPE IT'S A GOOD EXCUSE >> WORLD CUP

I wouldn’t, speak for yourself!

Moving on air. Insane MC and float.

57 years ago, i was 18 seems like yesterday when ya play it again

Bitcoin back to crash mode! Stocks too, especially tech imo, bought puts today!

now market rolls over...whoah!

Well, we were UP 20 cents at one point today - you know what that means.

some say that was their best one......" The Chicago Transit Authority "

What!!!! I was right!!! Omg!!!!

lol

More Great Breaking CBD News:

💥 https://www.sciencedirect.com/science/article/pii/S2707368826000361

💥 https://pubmed.ncbi.nlm.nih.gov/41421545/

💥 https://pubmed.ncbi.nlm.nih.gov/42298090/

💥 https://themarijua

VTGN: In @ 71 avg. Looks like Ph 3 data by EOM and I like the 42% Inst. Holdings
In Overbought territory, so if it dips further, I'll add.
Thanks

https://investorshub.advfn.com/uimage/uploads/2026/6/17/uhuwaScreenshot_2026-06-17_at_15-20-30_VTGN_SharpCharts_StockCharts.c

Hey SPORTY,
Have you checked out $ATWT lately? They acquired leading heavy civil and infra company and up listing to OTCQB.

GPUS GPUS GPUS 
Thread
•••
On June 15, 2026, said its Alliance Cloud Services unit is in advanced talks on a master services agreement to deliver 20 megawatts of Al-focused colocation and related data center services at its Michigan campus, a contract it estimates could exceed $

15 millions shares today and no bump. good grief

Last trade : 150 shrs .005

FORTUNE
BUSINESS INSIGHTS
THX, nice to be mentioned with some heavy hitters

June 2026: AbbVie received approval from the European Commission for AQUIPTA (atogepant) for the acute treatment of migraine in adults with or without aura, to be taken as needed (PRN). This appr

So far it has not moved the needle at all. Probably because after all that has come from the mouths of this family leadership with no follow through, the market is apathetic to this companies PR's and hype. Plus why get excited about another distributor when SO MANY others (established, not 'start u

if you see that



it will be a 2 for 1 @ $200, or 3 for 1 at $300 ...imho

This company specializes in sending out prototypes. They need a strategy to actually sell their motors. Do you think they realize they actually need to sell and have some revenue?